CP-358,774
Term · Oncology and biomedicine · MLC-T-ONC-002109
A drug used alone to treat certain types of non-small cell lung cancer and with gemcitabine hydrochloride to treat certain types of pancreatic cancer. It is also being studied in the treatment of other types of cancer. CP-358,774 blocks a protein called EGFR, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called erlotinib hydrochloride, OSI-774, and Tarceva.
| Identifier | MLC-T-ONC-002109 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | erlotinib hydrochloride; Tarceva |
| Synonyms | OSI-774 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-002109",
"term": "CP-358,774",
"field": "Oncology and biomedicine",
"definition": "A drug used alone to treat certain types of non-small cell lung cancer and with gemcitabine hydrochloride to treat certain types of pancreatic cancer. It is also being studied in the treatment of other types of cancer. CP-358,774 blocks a protein called EGFR, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called erlotinib hydrochloride, OSI-774, and Tarceva.",
"expansions": [
"erlotinib hydrochloride",
"Tarceva"
],
"synonyms": [
"OSI-774"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/cp-358774/"
}
Record 5,388 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.